The efficacy and safety of arsenic trioxide added transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
Phase of Trial: Phase IV
Latest Information Update: 08 Jan 2014
At a glance
- Drugs Arsenic trioxide; Epirubicin
- Indications Liver cancer
- Focus Therapeutic Use
- 30 Sep 2012 Status changed from not yet recruiting to completed as reported by Chinese Clinical Trial Register.
- 15 Sep 2009 New trial record